COzaar in Marfan PAtients Reduces aortic Enlargement - COMPARE


Data from murine models of Marfan’s syndrome suggest that losartan, which blocks the action of transforming growth factor (TGF)-beta, may result in improvements in aortic dimensions. The current trial sought to compare outcomes after administration of losartan versus placebo in patients with known Marfan’s syndrome.